Kandarpa Kumar Saikia
Overview
Explore the profile of Kandarpa Kumar Saikia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nath S, Bhattacharyya J, Sarma P, Saxena R, Sazawal S, Barman M, et al.
Indian J Hematol Blood Transfus
. 2020 Oct;
36(4):749-753.
PMID: 33100721
Expression of Epidermal Growth Factor Receptor (), an important proto-oncogene, regulates cell differentiation, proliferation, cell migration and survival in most of the cancer types. expression has been reported in Acute...
2.
Nath S, Bhattacharyya J, Chandra P, Saxena R, Sazawal S, Saikia K
Hematol Oncol Stem Cell Ther
. 2020 Aug;
15(2):54-57.
PMID: 32755558
Objective/background: Acute myeloid leukemia (AML) is one of the common forms of hematological malignancy and acute promyelocytic leukemia (APL) is a unique subtype of AML conferring favorable prognosis. We aimed...
3.
Saikia K, Panigrahi M, Mehta A, Kumar D
Indian J Surg Oncol
. 2018 Oct;
9(3):381-386.
PMID: 30288002
pathway is one of the important signaling pathways in cells, which is involved in cell proliferation, cell survival, motility, and growth. Mutation in gene negatively effects to anti-HER2 therapy in...
4.
Sarma D, Chauhan V, Saikia K, Sarma P, Nath S
Indian J Endocrinol Metab
. 2018 Jun;
22(2):229-235.
PMID: 29911037
Aims: To investigate the association between Vitamin D receptor gene polymorphisms (BsmI, TaqI and FokI) and type 2 diabetes mellitus in patients in north eastern India. Settings And Design: This...
5.
Bhattacharyya J, Nath S, Saikia K, Saxena R, Sazawal S, Barman M, et al.
Indian J Hematol Blood Transfus
. 2018 Feb;
34(1):32-42.
PMID: 29398797
Acute Myeloid Leukaemia (AML) is one of the common forms of haematological malignancy in adults. We analysed the prevalence and clinical significance of FMS-like tyrosine kinase 3 (FLT3) and Nucleophosmin...
6.
Kumar D, Mehta A, Panigrahi M, Nath S, Saikia K
Turk J Haematol
. 2017 Nov;
35(1):49-53.
PMID: 29129825
Objective: Nucleophosmin-1 (NPM1) mutations have prognostic importance in acute myeloid leukemia (AML) patients with intermediate-risk karyotype at diagnosis. Approximately 30% of newly diagnosed cytogenetically normal AML (CN-AML) patients harbor the...
7.
Kumar D, Mehta A, Panigrahi M, Nath S, Saikia K
Hematol Oncol Stem Cell Ther
. 2017 Oct;
11(2):82-89.
PMID: 29079128
Objective/background: In the absence of high-risk cytogenetic, DNMT3A (DNA Methyltransferase 3a) mutation status has an impact on outcome in the presence of FLT3 (FMS-like Tyrosine Kinase3) and/or NPM1 (Nucleophosmin). In...
8.
Panigrahi M, Kumar D, Mehta A, Saikia K
South Asian J Cancer
. 2017 Jul;
6(2):45-46.
PMID: 28702401
Background And Objectives: HER2 testing guideline of ASCO/CAP for interpretation and reporting has recently been revised. The study is aimed to measure the impact of 2013 CAP guideline on equivocal...
9.
Panigrahi M, Kumar D, Mehta A, Suryavanshi M, Bhurani D, Saikia K
Indian J Hematol Blood Transfus
. 2017 Jun;
33(2):271-272.
PMID: 28596663
Main objective of this work was to confirm the occurrence of rare BCR-ABL fusion variant involving the a2 region of the ABL gene and e8 of BCR gene in a...
10.
Kumar D, Panigrahi M, Suryavanshi M, Mehta A, Saikia K
J Clin Diagn Res
. 2016 Oct;
10(9):BC01-BC03.
PMID: 27790419
Introduction: Mutation detection from Formalin Fixed Paraffin-Embedding (FFPE) tissue in molecular lab became a necessary tool for defining potential targeted drug. Accurate quantification of DNA extracted from FFPE tissue is...